Value of Interleukin 6 in Assessment of the Disease Severity in Patients with COVID-19 Infection without Preexisting Comorbidities

AH Lashin, A El-Ghafar, A Osama… - Benha Medical …, 2023 - journals.ekb.eg
Background: In December of 2019, Wuhan, a new coronavirus-caused pandemic of atypical
pneumonia was reported by China. The World Health Organization (WHO) finally …

[HTML][HTML] Evaluation of interleukin-6 and its association with the severity of disease in COVID-19 patients

S Bhandari, G Rankawat, A Singh… - Indian Journal of …, 2020 - journals.lww.com
Background: The present study was undertaken to determine the levels of interleukin-6 (IL-
6) and evaluate its association with clinical presentation, severity, radiological imaging …

[PDF][PDF] KR Study correlating interleukin-6 levels with demographics, symptomatology and clinical outcomes among COVID-19 patients

AH Wahid, V Shenoy - Int J Adv Med, 2021 - academia.edu
Background: The objective of this study was to estimate the Interleukin-6 levels of COVID 19
patients and to find any associations between Interleukin-6 levels and age, gender, co …

Assessment of interleukin-6 role in detecting coronavirus disease 2019 severity, mortality, and its control: A cohort study

HM Shalaby, SS Abd ElMaksoud… - The Egyptian Journal …, 2023 - journals.lww.com
Assessment of interleukin-6 role in detecting coronavirus di... : The Egyptian Journal of Chest
Diseases and Tuberculosis Assessment of interleukin-6 role in detecting coronavirus disease …

[PDF][PDF] Interleukin-6 evaluation as a biomarker for disease severity and mortality in covid 19 patients

R Prasad, M Awasthi, S Kag, S Sethia - pisrt.org
Background: In pandemic situations, it is essential that the limited resources are used
judiciously to achieve most benefits. Prediction of the disease severity at the earliest will …

Elevated interleukin (IL)-6 as a predictor of disease severity among Covid-19 patients: a prospective cohort study

B Nikkhoo, M Mohammadi, S Hasani, N Sigari… - BMC Infectious …, 2023 - Springer
Background accompanied to the spreading of coronavirus disease 2019 (Covid-19) in the
world, identifying factors related to the severity of the disease is one of the interests of …

[PDF][PDF] Association of interleukin-6 levels with morbidity and mortality in patients with coronavirus disease 2019 (COVID-19)

J Zhou, W He, J Liang, L Wang, X Yu, M Bao, H Liu - Jpn J Infect Dis, 2021 - niid.go.jp
The prognostic value of interleukin-6 in COVID-19 needs to be clarified. In this retrospective
study, COVID-19 patients treated in Renmin Hospital of Wuhan University from Jan 7 to Feb …

Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19.

SBZ Mahmood, H Majid, A Arshad… - Clinical …, 2023 - search.ebscohost.com
Abstract Background: Interleukin-6 (IL-6) has been known to be involved in immune
regulation, inflammatory response, and metabolism. It is also recognized as the major cause …

[PDF][PDF] Study of Serum Interleukin-6 in COVID-19 Patients in Tertiary Care Hospital, Jharkhand

MH Raghu, R kumar Mahli - academia.edu
Aims: This study was aimed to measure and evaluate the serum interleukin-6 level in
diagnosed cases of COVID-19 Patients. Study design: An observational study. Place and …

[PDF][PDF] Interleukin 6 Levels and their Correlation with Various Hematological and Biochemical Parameters in Covid-19 Patients

RS Rasheed, S Salim - Al-Kindy College Medical Journal, 2023 - iasj.net
Background: coronavirus 19 is a beta-coronavirus, enveloped and roughly spherical with
approximately 60 to 140 nm in diameter with positive-sense single-stranded RNA genome …